Abstract
Continuous manufacturing in the pharmaceutical industry is an emerging technology, although it is widely practiced in industries such as petrochemical, bulk chemical, foods, and mineral processing. This chapter briefly discusses the characteristics of continuous manufacturing at the conceptual level, first, in its generic form, viewing the process as a unitary system, and then as a system composed of multiple manufacturing unit operations. Key requirements for implementing an effective continuous process are reviewed, while aspects specific to pharmaceutical applications are highlighted. The advantages and limitations of continuous manufacturing are discussed and compared to the advantages and limitations of the batch operating mode, which has been the mainstay of the pharmaceutical industry. Perspectives on advancing pharmaceutical manufacturing in the Industry 4.0 era are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
CDER US FDA. Quality considerations for continuous manufacturing guidance for industry (draft guidance). February, 2019.; Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.html.
Ganesh S, Moreno M, Liu J, Gonzalez M, Nagy Z, Reklaitis GV. Sensor network for continuous tablet manufacturing. Comput Aided Chem Eng. 2018;44:2149–54.
Ierapetritou M, Muzzio F, Reklaitis GV. Perspectives on the continuous manufacturing of powder-based pharmaceutical processes. AICHE J. 2016;62:1846–62.
ISA-18.2. Management of alarm systems for the process industries. Research Triangle Park: available form ISA; 2009.
Lee SL, O’Connor TF, Yang X, Cruz CN, Chatterjee S, Madurawe RD, et al. Modernizing pharmaceutical manufacturing: from batch to continuous production. J Pharm Innov. 2015;10(3):191–9.
Moreno M, Liu J, Su Q, Leach C, Giridhar A, Yazdanpanah N, O’Connor T, Nagy ZK, Reklaitis GV. Steady-state data reconciliation of a direct continuous tableting line. J Pharm Innov. (on line 9/2018., https://doi.org/10.1007/s12247-018-9354-9).
Muller TL. Sulfuric acid and sulfur trioxide. In: Kirk-Othmer encyclopedia of chemical technology. Hoboken: Wiley; 2006.
Seborg DE, Edgar TF, Mellichamp DA, Doyle FJ. Process dynamics and control. 3rd ed: Wiley; 2011. Chapt 2. Hoboken, NJ
Shinnar R. Use of residence- and contact-time distributions. In: Reactor design in chemical reactors and reaction engineering: Marcel-Dekker; 1986. Hoboken, NJ. p. 63–150.
Su Q, Ganesh S, Moreno M, Bommireddy Y, Gonzalez M, Reklaitis GV, Nagy ZK. A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing. Comput Chem Eng. 2019;125:216–31.
Venkatasubramanian V, Rengaswamy R, Yin K, Kavuri SN. A review of process fault detection and diagnosis part I: quantitative model-based methods. Comput Chem Eng. 2003;27:293–311.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Ganesh, S., Reklaitis, G.V. (2020). Basic Principles of Continuous Manufacturing. In: Nagy, Z., El Hagrasy, A., Litster, J. (eds) Continuous Pharmaceutical Processing. AAPS Advances in the Pharmaceutical Sciences Series, vol 42. Springer, Cham. https://doi.org/10.1007/978-3-030-41524-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-41524-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41523-5
Online ISBN: 978-3-030-41524-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)